Public Company News
Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry
Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem. SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- Viva Biotech announced today that it has been honored...
2025-09-29 17:00
1336
Yiren Digital Gains Increasing Momentum with Internet Insurance Business, Driving Strategic Second Growth Curve
Accelerating AI Innovation to Find New Growth Driver BEIJING, Sept. 29, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial services in Asia, announced increasing growth momentum in its intern...
2025-09-29 17:00
2604
S&P Global: World's No.1 PCS (>500kW) Market Share for Kehua
XIAMEN, China, Sept. 29, 2025 /PRNewswire/ -- According to the latest Energy Storage Inverter (PCS) Report 2025from S&P Global, Kehua Digital Energy (Kehua) has ranked first globally in the over 500kW PCS market segment, and has secured the position as the world's No.2 PCS supplier by market shar...
2025-09-29 16:24
1194
Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2025
BEIJING, Sept. 29, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China's leading used car retailer, today announced its unaudited financial results for the quarter endedJune 30, 2025. Highlights for the Quarter Ended June 30, 2025 * Transaction volume was 11,606 un...
2025-09-29 15:00
2846
The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development
SINGAPORE, Sept. 26, 2025 /PRNewswire/ -- The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded fromSeptember 24-26, 2025. The conference brought together leading biopharmaceutical companies and rese...
2025-09-27 10:45
3934
Datasea Reports Record Fiscal Year 2025 Revenue of $71.62 Million, Up 199% Year-over-Year
DTSS Achieves Fourth Quarter Net Income Breakeven Driven by Cutting-Edge Acoustics and AI Multimodal Digitalization; Ongoing Commercialization Updates in the Coming Weeks BEIJING, Sept. 26, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech ente...
2025-09-26 21:30
5574
Quhuo Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2025
BEIJING, Sept. 26, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading gig economy platform focusing on local life services inChina, today announced its unaudited financial results for the six months endedJune 30, 2025. Despite a challenging market environment a...
2025-09-26 20:42
4317
UCLOUDLINK's Groundbreaking PetPhone Launches on HKT's CSL Network in Hong Kong
HONG KONG, Sept. 26, 2025 /PRNewswire/ -- UCLOUDLINK GROUP INC. ("UCLOUDLINK" or the "Company") (NASDAQ: UCL), the world's first and leading mobile data traffic sharing marketplace, today announced that its groundbreaking product, PetPhone – the world's first smartphone for pets – has been formall...
2025-09-26 20:29
4721
Pony.ai Secures Robotaxi Testing Permit in Dubai, Accelerating Middle East Deployment
DUBAI, Sept. 26, 2025 /PRNewswire/ -- Pony.ai, a global leader in autonomous driving technology, today announced that it has been granted permit byDubai's Roads and Transport Authority (RTA) to conduct autonomous driving trials on the emirate's roads. This milestone follows the company's partners...
2025-09-26 20:08
2800
Concord Medical Reports Financial Results for the First Half of 2025
BEIJING, Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced its unaudited consolidated financial results for t...
2025-09-26 19:30
3520
Eason Technology Limited Filed Annual Report on Form 20-F for Fiscal Year 2024 and Regained Compliance with the NYSE American
HONG KONG, Sept. 26, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE American: DXF), a company engaged in real estate operation management and investment, and digital technology security business, today announced that it filed its annual report on Form 20...
2025-09-26 18:30
3428
BOE, UNESCO co-organize Science Decade side event at 5th WCBR in Hangzhou
HANGZHOU, China, Sept. 26, 2025 /PRNewswire/ -- The 5th World Congress of Biosphere Reserves (WCBR) opened inHangzhou on September 22, welcoming participation from over 100 countries and territories. This marks the first time that the event has taken place inChina and the Asia-Pacific region. As ...
2025-09-26 14:54
1935
Uxin Announces Grand Opening of Zhengzhou Used Car Superstore
BEIJING, Sept. 26, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China's leading used car retailer, today announced that its new used car superstore inZhengzhou, Henan Province will officially open on September 27, 2025. The Zhengzhou used car superstore has a gross ...
2025-09-26 14:00
3318
Yum China Recognized in Fortune's 2025 "Change the World" List for KFC's Food Bank Initiative
SHANGHAI, Sept. 25, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") has been named to Fortune's 2025 "Change the World" list, which recognizes companies that drive positive social impact through initiatives integrated into their core busines...
2025-09-26 11:11
2502
Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth
BEIJING, SHANGHAI and BOSTON, Sept. 25, 2025 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK)today announced that its Chairman and Chief Executive Officer, Dr. Yinxiang Wang, together with concerted parties, have recently increased their shareholding in the Company by 11.06 million shares, repr...
2025-09-26 08:47
1996
The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer
SAN FRANCISCO, Sept. 25, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of ...
2025-09-25 21:37
2299
NETMARBLE'S OPEN-WORLD RPG, THE SEVEN DEADLY SINS: ORIGIN, SET FOR GLOBAL RELEASE IN JANUARY 2026
* New Gameplay Trailer Revealed During State of Play; Pre-order Package for PlayStation® 5 Now Available * Tokyo Game Show Press Conference Unveiled Closed Beta Schedule SEOUL, South Korea, Sept. 25, 2025 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality games, ann...
2025-09-25 21:00
3090
Hesai Recognized on Fortune's 2025 Change the World List for Redefining Road Safety
PALO ALTO, Calif., Sept. 25, 2025 /PRNewswire/ -- Hesai Technology (NASDAQ:HSAI and HKEX:2525), the global leader in lidar solutions, has been named by Fortune, a global multiplatform media company, to its prestigious 2025Change the World list. Each year, Fortune's Change the World list highligh...
2025-09-25 21:00
2261
Locksley Names Industry Veterans CEO and COO to Fast-Track its US Mine-to-Market Effort
SAN BERNARDINO, Calif., Sept. 25, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQB: LKYRF) announced the appointment ofKerrie Matthews as Chief Executive Officer (CEO) andDanny George as Chief Operating Officer (COO) of the company. The appointments are newly-created positions and...
2025-09-25 20:20
3068
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™，to Accelerate Biologics Development with High Titer and Superior Stability
* TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability. * The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining sta...
2025-09-25 19:42
2015
Week's Top Stories
Most Reposted
Global virtual travel card program launched by Visa and Trip.com to make travel payments simpler and more seamless in Asia Pacific
[Picked up by 333 media titles]
2026-03-11 11:08PDG Targets USD 5 Billion Debt Raise
[Picked up by 297 media titles]
2026-03-11 10:00The Mastercard Collection: Savor the Extraordinary with Mastercard's Asia Gourmet Circle Program
[Picked up by 295 media titles]
2026-03-12 09:00Five Breakthrough AV Technologies: Dreame's Premium AV Brand INNIX Highlights a High-End Home Cinema Lineup at AWE 2026
[Picked up by 284 media titles]
2026-03-13 16:08
Travel providers to accept UnionPay cards for both direct e-Commerce bookings and in-direct sales via Amadeus Travel Platform
[Picked up by 283 media titles]
2026-03-12 11:00
Most Read
HTCO Launches U.S. Strategic Initiative Led by Chairman Christopher Nixon Cox, Establishes Independent Governance Committee for U.S. Operations
2026-03-13 21:30
6558
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
2026-03-13 21:59
5784